Star Vision Research | Burleson, TX

Research site

Site insights

Top conditions

Top treatments


Data sourced from

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 1 total trial
Locations recently updated

A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Moderately Severe to Severe Non-proliferative Diabetic Retinopathy (NPDR) (GLOW2)

This study will demonstrate that tarcocimab 5 mg is superior to sham treatment in participants with moderately severe to severe NPDR.

Non-proliferative Diabetic Retinopathy
Drug: Tarcocimab
Other: Sham injection

Trial sponsors

Kodiak Sciences logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems